Newsroom

Gruppenbild
News
Many people suffer from neurodermatitis (atopic dermatitis) or psoriasis. These chronic inflammatory diseases, which have so far been incurable, can lead to a significant loss of quality of life due to the agonising itching and stigmatisation in severe forms. Researchers of the exzellence cluster RESIST have now gained a number of new insights with potential clinical relevance using state-of-the-art technologies such as T-cell receptor and single-cell RNA sequencing based on skin biopsies and blood samples from patients. They have published these in the journal Allergy, currently the leading publication in the field of allergology, in two articles. The main authors include Dr Bowen Zhang from the research group of Prof Yang Li, Centre for Individualised Infection Medicine (CiiM) and TWINCORE - Centre for Experimental and Clinical Infection Research, and Dr Lennart Rösner and Dr Stephan Traidl from the team of Prof Thomas Werfel, Clinic for Dermatology, Allergology and Venereology at Hanover Medical School (MHH). The CiiM and TWINCORE are joint institutions of the Helmholtz Centre for Infection Research (HZI) in Braunschweig and MHH.
13.10.2022
Portrait of Peggy Riese
Interview
Dr Peggy Riese is a scientist in the Department of Vaccinology and Applied Microbiology at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany. Her research focuses on the special features of the immune system in its interaction with vaccines. In this interview, she talks about current developments in SARS-CoV-2 vaccine research.
11.10.2022
The HIPS exhibit on the MS Wissenschaft
Story
In their search for new substances that are effective against infectious diseases, researchers at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) are extracting natural substances from soil bacteria. They are getting help from the public in the course of a citizen science project, which this year recruited citizen scientists from all over Germany on board the exhibition ship “MS Wissenschaft”.
06.10.2022
Cattle market Bangladesh
Story
Founded in April 2022, the Helmholtz Institute for One Health (HIOH) in Greifswald is a new branch of the HZI. What exactly does One Health mean? And why is this research approach particularly important today?
03.10.2022
Christian Sieben
Portrait
Christian Sieben decided in favour of biology thanks to his older sister, also a biologist, who gave him an early glimpse behind the scenes of this field of study. But the 40-year old‘s career path was anything but classical. After completing his diploma in Darmstadt, he went to Berlin to do his doctorate - in the biophysics department of the Humboldt University. Although he had never been concerned with virology or microbiology during his studies, his research now focussed on influenza viruses and their initial cell contact using super-resolution microscopes for his doctoral thesis. A far-reaching decision: “It was at this time that the foundation for my research today was laid.”
01.10.2022
Pilz
News
The transfer of research results into application is an important goal of the scientists at the Helmholtz Centre for Infection Research (HZI) in Braunschweig. The GO-Bio initial programme of the German Federal Ministry of Education and Research (BMBF) is now funding two HZI projects for a one-year concept phase in which the application idea will be elaborated and an implementation strategy developed. The BASIDIOMICS project, led by Dr Frank Surup and Prof Marc Stadler from the department “Microbial Drugs” at the HZI in Braunschweig, is developing a platform to make clinically and industrially relevant secondary substances from fungi accessible. Stadler is also a scientist in the research area “Novel Antibiotics” at the German Center for Infection Research (DZIF). A new class of active substances against the tropical disease malaria is to be developed in the ChloroMalaria project, led by Dr Walter Hofer and Dr Jennifer Herrmann from the department “Microbial Natural Products” at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS). The HIPS is a site of the HZI in cooperation with Saarland University. The projects start on 01 October 2022.
28.09.2022

HZI in the media

... haben. Ein Forschungsteam des Helmholtz-Instituts für RNA-basierte Infektionsforschung (HIRI) in Würzburg hat in Zusammenarbeit ...

14.04.2026
|
PresseBox - DE

... der Infektion und Nozizeption“ am Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig. Nozizeption ist der Fachbegriff ...

14.04.2026
|
Verband Deutscher Biologen e.V.

... recht nicht bei Fabian Leendertz, der in Greifswald das „Helmholtz-Institut für One Health“ leitet. Im ...

14.04.2026
|
FAZ.NET

... sich auch das Helmholtz-Institut für Pharmazeutische Forschung Saarland ( HIPS ), das Helmholtz-Zentrum für Infektionsforschung ( HZI ) ...

09.04.2026
|
Deutsches Ärzteblatt

... ÖAW in Wien und nun Gruppenleiter am Helmholtz Zentrum für Infektionsforschung in Braunschweig, forscht an ...

08.04.2026
|
DerStandard.de

... group within the Microstar Program at the Helmholtz Centre for Infection Research (HZI) and a ...

31.03.2026
|
Informations Dienst Wissenschaft

... an der Medizinischen Hochschule Hannover und am Helmholtz Institut für Infektionen in Braunschweig die Wirkung ...

28.03.2026
|
Hamburger Abendblatt

led by wildlife veterinarian Fabian Leendertz, who heads the Helmholtz Institute for One Health, took hundreds of samples from meat and

27.03.2026
|
Science.org

Gesellschaft. Apropos Standort Braunschweig: Auch das Helmholtz-Zentrum für Infektionsforschung HZI, in dessen Räumlichkeiten auf dem ...

27.03.2026
|
transkript

Helmholtz Centre for Infection Research

 

After infection with SARS-CoV-2, up to 10 percent of people in Germany go on to develop Long COVID.

26.03.2026
|
Mirage.News

... von verschiedenen Hörnchen, wie jüngste Erkenntnisse des Helmholtz Instituts für One Health in Greifswald kürzlich ...

26.03.2026
|
Tagesschau

zur Bekämpfung der Tuberkulose und des Helmholtz-Zentrums für Infektionsforschung erstellt. Zahlreiche weitere Fachgesellschaften und

24.03.2026
|
Deutsches Ärzteblatt

Register now for the HZI-Newsletter